Switch theme
Sign up to access all valuation multiples
Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
2016
4.9K+
LTM Revenue $463M
LTM EBITDA $127M
$558M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Australian Clinical Labs has a last 12-month revenue of $463M and a last 12-month EBITDA of $127M.
In the most recent fiscal year, Australian Clinical Labs achieved revenue of $436M and an EBITDA of $107M.
Australian Clinical Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Australian Clinical Labs valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $438M | $436M | XXX | XXX | XXX |
| Gross Profit | $494M | $358M | XXX | XXX | XXX |
| Gross Margin | 113% | 82% | XXX | XXX | XXX |
| EBITDA | $110M | $107M | XXX | XXX | XXX |
| EBITDA Margin | 25% | 25% | XXX | XXX | XXX |
| Net Profit | $113M | $22.7M | XXX | XXX | XXX |
| Net Margin | 26% | 5% | XXX | XXX | XXX |
| Net Debt | n/a | $28.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 14, 2025, Australian Clinical Labs's stock price is AUD 3 (or $2).
Australian Clinical Labs has current market cap of AUD 587M (or $371M), and EV of AUD 882M (or $558M).
See Australian Clinical Labs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $558M | $371M | XXX | XXX | XXX | XXX | $0.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 14, 2025, Australian Clinical Labs has market cap of $371M and EV of $558M.
Australian Clinical Labs's trades at 1.2x LTM EV/Revenue multiple, and 4.4x LTM EBITDA.
Analysts estimate Australian Clinical Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Australian Clinical Labs and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $558M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 4.7x | XXX | XXX | XXX |
| P/E | 19.9x | XXX | XXX | XXX |
| P/E/Growth | 0.9x | XXX | XXX | XXX |
| EV/FCF | 7.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAustralian Clinical Labs's NTM/LTM revenue growth is 6%
Australian Clinical Labs's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Australian Clinical Labs's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Australian Clinical Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Australian Clinical Labs and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -3% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 32% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 45% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 75% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Australian Clinical Labs acquired XXX companies to date.
Last acquisition by Australian Clinical Labs was XXXXXXXX, XXXXX XXXXX XXXXXX . Australian Clinical Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Australian Clinical Labs founded? | Australian Clinical Labs was founded in 2016. |
| Where is Australian Clinical Labs headquartered? | Australian Clinical Labs is headquartered in Australia. |
| How many employees does Australian Clinical Labs have? | As of today, Australian Clinical Labs has 4.9K+ employees. |
| Who is the CEO of Australian Clinical Labs? | Australian Clinical Labs's CEO is Ms. Melinda McGrath. |
| Is Australian Clinical Labs publicy listed? | Yes, Australian Clinical Labs is a public company listed on ASX. |
| What is the stock symbol of Australian Clinical Labs? | Australian Clinical Labs trades under ACL ticker. |
| When did Australian Clinical Labs go public? | Australian Clinical Labs went public in 2021. |
| Who are competitors of Australian Clinical Labs? | Similar companies to Australian Clinical Labs include e.g. Healius, Integral Diagnostics, Sonic Healthcare, Bangkok Dusit Medical Services. |
| What is the current market cap of Australian Clinical Labs? | Australian Clinical Labs's current market cap is $371M |
| What is the current revenue of Australian Clinical Labs? | Australian Clinical Labs's last 12-month revenue is $463M. |
| What is the current EBITDA of Australian Clinical Labs? | Australian Clinical Labs's last 12-month EBITDA is $127M. |
| What is the current EV/Revenue multiple of Australian Clinical Labs? | Current revenue multiple of Australian Clinical Labs is 1.2x. |
| What is the current EV/EBITDA multiple of Australian Clinical Labs? | Current EBITDA multiple of Australian Clinical Labs is 4.4x. |
| What is the current revenue growth of Australian Clinical Labs? | Australian Clinical Labs revenue growth between 2023 and 2024 was 0%. |
| Is Australian Clinical Labs profitable? | Yes, Australian Clinical Labs is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
